Kezdőlap・Részvénylista・Champions Oncology Inc

C
Champions Oncology Inc

Nyitva

SzektorEgészségügy

5.37 0.19

Vétel Eladás

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

5.26

Maximum

5.55

Fő mutatók
By Trading Economics
Bevétel	-389K -667K
Értékesítés	1.5M 17M
P/E Szektor átlag	35.118 64.641
Egy részvényre jutó nyereség	-0.05
Profit margin	-4.028
Munkavállalók	213
EBITDA	-626K -522K

Osztalékok
By Acuity
Következő eredményjelentés	2026. szept. 11.

Piaci statisztika
By TradingEconomics
Piaci kapitalizáció	-555K 84M
Előző nyitás	5.18
Előző zárás	5.37

Hangulat hírek alapján

By Acuity

15%

85%

25 / 340 Rangsor szerint Healthcare

Champions Oncology Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. aug. 3. 20:13 UTC

Champions Oncology Inc shares are trading higher in after-market hours. Broader market momentum is supported by strong tech performances and positive sentiment ahead of economic data.

2026. júl. 31. 19:46 UTC

Champions Oncology Inc shares are higher today, reflecting a positive move since Thursday's close, though still below the 20-day moving average.

2026. júl. 30. 17:16 UTC

Champions Oncology is trading lower today, continuing a trend of declines over the past three sessions, despite positive broader market sentiment.

2026. júl. 29. 19:02 UTC

Champions Oncology Inc is trading higher during Wednesday's session, breaking from its recent upward trend. Broader market dynamics are influenced by rising oil prices.

2026. júl. 28. 19:32 UTC

Champions Oncology Inc. shares are trading lower amid broader market declines, particularly in technology sectors across Asia, with no specific company news identified.

2026. júl. 27. 23:01 UTC

News

Champions Oncology shares declined in after-market trading following mixed fourth-quarter earnings, despite adjusted EPS of $0.01 and record annual revenue of $59.4 million.

2026. júl. 24. 20:06 UTC

Champions Oncology Inc shares are advancing, despite earlier intraday volatility. Broader market sentiment reflects easing inflation concerns amid significant oil price drops.

2026. júl. 22. 19:41 UTC

Champions Oncology shares are declining during Wednesday's session, with no specific news identified. Broader market concerns are driven by rising crude oil prices.

Társak összehasonlítása

Árváltozás

Champions Oncology Inc Előrejelzés

Értékelési konszenzus

By TipRanks

0 ratings

Vétel

Tartás

Eladás

0 Wall Street elemző célárain alapulva a(z)Champions Oncology Inc termékhez az elmúlt 3 hónapban.

Hangulat

By Acuity

25 / 340 Rangsor szerint Egészségügy

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

Rólunk Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.